Fujifilm shares tumble after report Avigan not showing apparent efficacy in coronavirus treatment

Shares of Fujifilm Holdings Corp tumbled more than 4% in early trade on Wednesday after a report its anti-flu drug Avigan was not showing apparent efficacy in coronavirus treatment in clinical trials so far.